C-REL Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52.
Synonyms
Avian reticuloendotheliosis; c Rel proto oncogene protein; Oncogene REL; Proto-oncogene c-Rel; REL.
Gene ID
5966
Swiss Prot
Q04864
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Target
C-REL
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human c Rel
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-61664R-Cy7
Gene ID URL
5966
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15103671 1 Vial
Lentiviral human LCE1E shRNA (UAS) - Lentiviral human LCE1E shRNA (UAS, iRFP) (100)
Ask
View Details